Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06550362

Daily Iron vs Every-other-day Iron for Pediatric Patients With IDA

A Randomized Controlled Trial Comparing Daily Oral Iron Administration to Every Alternate Day Iron Administration in the Treatment of Iron Deficiency Anemia in Pediatric Patients.

Status
Not Yet Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Loma Linda University · Academic / Other
Sex
All
Age
1 Year – 18 Years
Healthy volunteers
Not accepted

Summary

Iron Deficiency Anemia (IDA) is a prevalent global health issue affecting a significant proportion of the population, including children. While daily oral iron supplementation is a common approach to treat IDA, concerns regarding side effects and compliance have led to exploration of alternative dosing schedules, such as every-other-day. This study aims to investigate the efficacy and safety of daily versus every other day oral iron supplementation in the management of IDA in pediatric patients.

Detailed description

This is a prospective open-label randomized controlled study. Patients will be randomized into two groups, one group (investigational) will receive oral iron every other day (every 48 hours) and the control group will be prescribed daily oral iron. Data will be collected prospectively including compliance assessment, side effect profile, hemoglobin (CBC), iron stores, hepcidin levels and other monitoring as relevant for best patient care. At the time of enrollment and following randomization patients will commence treatment with oral iron. Duration of treatment will be 3 months. Laboratory monitoring will also commence at the time of enrollment along with ongoing evaluation of signs and symptoms of anemia, side effects of oral iron therapy, compliance with oral iron therapy. Duration of monitoring will be 6 months. A medication diary will be provided to all subjects of each group to track their intake of their oral iron supplementation.

Conditions

Interventions

TypeNameDescription
DRUGiron sulfateOral iron administration

Timeline

Start date
2026-05-01
Primary completion
2027-05-01
Completion
2027-05-01
First posted
2024-08-13
Last updated
2026-01-30

Source: ClinicalTrials.gov record NCT06550362. Inclusion in this directory is not an endorsement.